Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The introduction of an anti-C5 antibody in 2007 increased confidence in complement-targeted therapy. However, it has been shown that inhibition of late-stage effector formation in multifactorial complement disorders may not be sufficient.
…